VITREOMACULAR TRACTION SYNDROME FOLLOWING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN AIDS PATIENTS WITH CYTOMEGALOVIRUS RETINITIS

Abstract

VMT appears to be a sequelae of HAART-associated immune recovery vitritis in AIDS-related CMV-R. Changes in immune status may permit an inflammatory response that can lead to VMT. As advances in pharmacologic intervention continue, clinical manifestations and ocular sequelae in CMV-R will change, as will the approach and management of this disease.